The 5-year outcomes of moderately hypofractionated radiotherapy (66 Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study

References

Page 1

	Year	Citations
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer Anthony V. D’Amico JAMA	1998	4.5K
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Mack Roach, Gerald E. Hanks, Howard D. Thames, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineUrologyRadiation TherapyGenitourinary CancerMedicine	2006	2.7K
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial David P. Dearnaley, Isabel Syndikus, Helen Mossop, The Lancet Oncology	2016	1.3K
Dose-Fractionation Sensitivity of Prostate Cancer Deduced From Radiotherapy Outcomes of 5,969 Patients in Seven International Institutional Datasets: α/β = 1.4 (0.9–2.2) Gy Raymond Miralbell, Stephen A. Roberts, Eduardo Zubizarreta, International Journal of Radiation OncologyBiologyPhysics Radiation TestingRadiation MedicineUrologyTreatment VerificationMedicine	2011	505
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial Shafak Aluwini, Floris J. Pos, Erik C. Schimmel, The Lancet Oncology Radiation MedicineRadiation TherapyMedicineBrachytherapyLate Toxicity Results	2016	308
Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer Stefano Arcangeli, Lidia Strigari, Sara Gomellini, International Journal of Radiation OncologyBiologyPhysics UrologyHigh-risk Prostate CancerMedicineBenign Prostatic HyperplasiaRandomized Hypofractionation Trial	2012	192
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Long-term outcomes Patrick A. Kupelian, V.V. Thakkar, Deepak Khuntia, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicineLocalized Prostate CancerIntensity-modulated RadiotherapyRadiation Therapy Planning	2005	191
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial Anna Wilkins, Helen Mossop, Isabel Syndikus, The Lancet Oncology	2015	149
Hypofractionated conformal radiotherapy in carcinoma of the prostate: five-year outcome analysis Jacqueline E. Livsey, Richard Cowan, James Wylie, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyConformal RadiotherapyFive-year Outcome AnalysisProstatic DiseaseRadiation Oncology	2003	143
Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding Tetsuo Akimoto, Hiroyuki Muramatsu, Mitsuhiro Takahashi, International Journal of Radiation OncologyBiologyPhysics Surgical OncologyRectal BleedingRadiation TherapyMedicineWorse Rectal Bleeding	2004	102

Page 1